Is Prothena Plc Stock a Good Investment?

Prothena Plc Investment Advice

  PRTA
To provide specific investment advice or recommendations on Prothena plc stock, we recommend investors consider the following general factors when evaluating Prothena plc. This will help you to make an informed decision on whether to include Prothena Plc in one of your diversified portfolios:
  • Examine Prothena Plc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Prothena Plc's leadership team and their track record. Good management can help Prothena Plc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Prothena Plc's business and its evolving consumer preferences.
  • Compare Prothena Plc's performance and market position to its competitors. Analyze how Prothena Plc is positioned in terms of product offerings, innovation, and market share.
  • Check if Prothena Plc pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Prothena Plc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Prothena plc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Prothena plc is a good investment.
 
Sell
 
Buy
Strong Hold
Our trade recommendations tool can cross-verify current analyst consensus on Prothena plc and to analyze the firm potential to grow in the current economic cycle. To make sure Prothena Plc is not overpriced, please check all Prothena plc fundamentals, including its price to sales, debt to equity, number of employees, as well as the relationship between the net income and short ratio . Given that Prothena plc has a price to earning of 37.12 X, we recommend you to check out Prothena plc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Not too volatileDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Prothena Plc Stock

Researching Prothena Plc's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prothena plc has Price/Earnings To Growth (PEG) ratio of 0.8. The entity recorded a loss per share of 2.46. The firm had not issued any dividends in recent years.
To determine if Prothena Plc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Prothena Plc's research are outlined below:
Prothena plc generated a negative expected return over the last 90 days
Prothena plc has high historical volatility and very poor performance
The company reported the previous year's revenue of 91.37 M. Net Loss for the year was (147.03 M) with loss before overhead, payroll, taxes, and interest of (81.66 M).
Prothena plc currently holds about 508.8 M in cash with (133.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.84.
Prothena plc has a poor financial position based on the latest SEC disclosures
Over 97.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
Prothena Plc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Prothena plc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Prothena Plc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Prothena Plc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Prothena Plc's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-02-12
2019-12-31-0.6-0.540.0610 
2015-11-02
2015-09-30-0.66-0.73-0.0710 
2022-05-05
2022-03-31-0.68-0.78-0.114 
2019-05-07
2019-03-31-0.62-0.520.116 
2013-11-12
2013-09-30-0.66-0.550.1116 
2020-11-04
2020-09-30-0.65-0.77-0.1218 
2014-11-03
2014-09-30-0.6-0.480.1220 
2013-08-12
2013-06-30-0.52-0.64-0.1223 

Know Prothena Plc's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Prothena Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prothena plc backward and forwards among themselves. Prothena Plc's institutional investor refers to the entity that pools money to purchase Prothena Plc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2024-09-30
719.3 K
Boxer Capital Llc2024-09-30
690 K
Rock Springs Capital Management Lp2024-09-30
625 K
Ubs Asset Mgmt Americas Inc2024-09-30
526.7 K
Prosight Management, Lp2024-09-30
483.5 K
Finepoint Capital Lp2024-09-30
433.5 K
Goldman Sachs Group Inc2024-09-30
415.3 K
Federated Hermes Inc2024-09-30
404.9 K
Northern Trust Corp2024-09-30
372.7 K
Ecor1 Capital, Llc2024-09-30
11.6 M
Fmr Inc2024-09-30
8.1 M
Note, although Prothena Plc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Prothena Plc's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 741.48 M.

Market Cap

978.42 Million

Prothena Plc's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.21)(0.22)
Return On Capital Employed(0.30)(0.28)
Return On Assets(0.21)(0.22)
Return On Equity(0.26)(0.25)
The company has Profit Margin (PM) of (0.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (68.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $68.57.
Determining Prothena Plc's profitability involves analyzing its financial statements and using various financial metrics to determine if Prothena Plc is a good buy. For example, gross profit margin measures Prothena Plc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Prothena Plc's profitability and make more informed investment decisions.
Please note, the presentation of Prothena Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prothena Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Prothena Plc's management manipulating its earnings.

Evaluate Prothena Plc's management efficiency

Prothena plc has return on total asset (ROA) of (0.1566) % which means that it has lost $0.1566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.229) %, meaning that it created substantial loss on money invested by shareholders. Prothena Plc's management efficiency ratios could be used to measure how well Prothena Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2024, Return On Tangible Assets is expected to decline to -0.22. The current year's Return On Capital Employed is expected to grow to -0.28. At present, Prothena Plc's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 16.1 M, whereas Total Assets are forecasted to decline to about 414.8 M.
Last ReportedProjected for Next Year
Book Value Per Share 10.55  7.17 
Tangible Book Value Per Share 10.55  7.20 
Enterprise Value Over EBITDA(6.98)(7.33)
Price Book Value Ratio 3.44  3.62 
Enterprise Value Multiple(6.98)(7.33)
Price Fair Value 3.44  3.62 
Enterprise Value1.2 B618.2 M
Understanding the operational decisions made by Prothena Plc management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta
0.158

Basic technical analysis of Prothena Stock

As of the 4th of December, Prothena Plc holds the Variance of 19.63, risk adjusted performance of (0.1), and Coefficient Of Variation of (708.18). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prothena Plc, as well as the relationship between them.

Prothena Plc's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prothena Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prothena Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Prothena Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Prothena Plc's Outstanding Corporate Bonds

Prothena Plc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Prothena plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Prothena bonds can be classified according to their maturity, which is the date when Prothena plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Prothena Plc's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Prothena Plc's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Prothena Plc's intraday indicators

Prothena Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Prothena Plc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Prothena Plc Corporate Filings

13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
10Q
12th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
13A
8th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F3
3rd of October 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
Prothena Plc time-series forecasting models is one of many Prothena Plc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prothena Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Prothena Stock media impact

Far too much social signal, news, headlines, and media speculation about Prothena Plc that are available to investors today. That information is available publicly through Prothena media outlets and privately through word of mouth or via Prothena internal channels. However, regardless of the origin, that massive amount of Prothena data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Prothena Plc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Prothena Plc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Prothena Plc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Prothena Plc alpha.

Prothena Plc Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Prothena Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Prothena Plc Corporate Management

Hideki MDChief OfficerProfile
CPA CPAChief ControllerProfile
Jennifer ZibudaDirector CommunicationProfile
Brandon SmithChief OfficerProfile
Wagner ZagoChief Scientific OfficerProfile
Carol KarpChief Regulatory OfficerProfile
David FordChief OfficerProfile
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Revenue Per Share
2.482
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.16)
Return On Equity
(0.23)
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Prothena Plc's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.